Literature DB >> 409090

Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain.

A S Dekaban, G Constantopoulos.   

Abstract

Histochemical and electron microscopic studies of the brains inclusive of the leptomeninges containing large blood vessels from 7 patients with mucopolysaccharidosis (MPS) I, II, IIIA and V showed marked increase in mesenchymal elements and the generalized presence of characteristic lesions around cerebral veins and arteries. The periadventitial space was greatly distended and filled with viscous fluid and numerous mononuclear cells containing large cytoplasmic vacuoles; these cells stained positively for glycosaminoglycans (GAG). In contrast, the neurons showed only a slight increase of GAG over the normal controls but contained an excessive amount of glycolipid-like material. The amount of GAG in the leptomeninges, inclusive of the large blood vessels, was 10.8, 6.5, 4.5 and 2.2 times greater in patients with MPS I, II, V and IIIA respectively, than the mean of unaffected controls. Dermatan sulfate (DS) accounted for most of the GAG increase in MPS I, II and V [mixed excretors of DS and heparan sulfate (HS)], and HS for the GAG increase in MPS IIIA (HS excretor). With the exception of the patient with MPS IIIA, whose GAG content and composition were the same in both the neural and mesenchymal elements, in all the other MPS types the mesenchymal elements contained more GAG, with a preponderance of DS. We conclude that the mesenchymal elements contribute substantially to the increased content of GAG in the brain and its coverings, mostly in the form of dermatan sulfate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 409090     DOI: 10.1007/bf00690379

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Gargoylism (lipochondrodystrophy); a study of 10 cases, with emphasis on the formes frustes of the disease.

Authors:  G A JERVIS
Journal:  Arch Neurol Psychiatry       Date:  1950-05

2.  Distribution and metabolism of mucopolysaccharides and glycoproteins in neuronal perikarya, astrocytes, and oligodendroglia.

Authors:  R U Margolis; R K Margolis
Journal:  Biochemistry       Date:  1974-07-02       Impact factor: 3.162

3.  Hurler's and Sanfilippo's variants of mucopolysaccharidosis. Cerebral pathology and lipid chemistry.

Authors:  A S Dekaban; V M Patton
Journal:  Arch Pathol       Date:  1971-05

4.  A rapid and micro method for separation of acidic glycosaminoglycans by two-dimensional electrophoresis.

Authors:  R Hata; Y Nagai
Journal:  Anal Biochem       Date:  1972-02       Impact factor: 3.365

5.  [Catabolic mucopolysaccharide protein metabolism in human organs].

Authors:  D Platt; U Stein
Journal:  Z Klin Chem Klin Biochem       Date:  1969-07

6.  The vascular architecture of the cortex and the cortical blood flow.

Authors:  G Lazorthes; J Espagno; Y Lazorthes; J O Zadeh
Journal:  Prog Brain Res       Date:  1968       Impact factor: 2.453

7.  Quantitative anatomy of the cerebral vascular bed with especial emphasis on homogeneity and inhomogeneity in small ports of the gray and white matter.

Authors:  W Lierse; E Horstmann
Journal:  Acta Neurol Scand Suppl       Date:  1965

8.  The mucopolysaccharidoses (a review).

Authors:  A Dorfman; R Matalon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

Review 9.  Inherited disorders of lysosomal metabolism.

Authors:  E F Neufeld; T W Lim; L J Shapiro
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

10.  Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.

Authors:  A S Dekaban; G Constantopoulos; M M Herman; J K Steusing
Journal:  Arch Pathol Lab Med       Date:  1976-05       Impact factor: 5.534

View more
  21 in total

1.  Neuropathological and clinical correlations in Hurler disease.

Authors:  R W Watts; E Spellacy; J H Adams
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

Review 2.  Brain and spinal MR imaging findings in mucopolysaccharidoses: a review.

Authors:  D I Zafeiriou; S P Batzios
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

3.  Glycosaminoglycan storage in neuroanatomical regions of mucopolysaccharidosis I dogs following intrathecal recombinant human iduronidase.

Authors:  Agnes Chen; Carole Vogler; Michael McEntee; Stephen Hanson; N Matthew Ellinwood; Jackie Jens; Elizabeth Snella; Merry Passage; Steven Le; Catalina Guerra; Patricia Dickson
Journal:  APMIS       Date:  2011-05-14       Impact factor: 3.205

4.  Computed tomography studies on patients with mucopolysaccharidoses.

Authors:  R W Watts; E Spellacy; B E Kendall; G du Boulay; D A Gibbs
Journal:  Neuroradiology       Date:  1981-02       Impact factor: 2.804

5.  Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III).

Authors:  Björn Kowalewski; Peter Heimann; Theresa Ortkras; Renate Lüllmann-Rauch; Tomo Sawada; Steven U Walkley; Thomas Dierks; Markus Damme
Journal:  Hum Mol Genet       Date:  2014-12-01       Impact factor: 6.150

6.  A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs.

Authors:  N M Ellinwood; P Wang; T Skeen; N J H Sharp; M Cesta; S Decker; N J Edwards; I Bublot; J N Thompson; W Bush; E Hardam; M E Haskins; U Giger
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

7.  Cerebral MRI in two brothers with mucopolysaccharidosis type I and different clinical phenotypes.

Authors:  O Gabrielli; U Salvolini; M Maricotti; M G Mariani; G V Coppa; P L Giorgi
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

8.  Mucopolysaccharidosis: thickening of dura mater at the craniocervical junction and other CT/MRI findings.

Authors:  A Taccone; P Tortori Donati; A Marzoli; A Dell'Acqua; R Gatti; D Leone
Journal:  Pediatr Radiol       Date:  1993

9.  MRI in the mild type of mucopolysaccharidosis II (Hunter's syndrome).

Authors:  N Shinomiya; T Nagayama; Y Fujioka; T Aoki
Journal:  Neuroradiology       Date:  1996-07       Impact factor: 2.804

Review 10.  Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed.

Authors:  S Al Sawaf; E Mayatepek; B Hoffmann
Journal:  J Inherit Metab Dis       Date:  2008-07-13       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.